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Brugada pattern “coved” type (Fig. 1). The echocardiogramwas normal.
The history of syncope or family history of sudden death was negative.
He underwent anti-inﬂammatory drug therapy with high dose of para-
cetamol and at the defervescence of fever, in conjunction with the
regression of chest pain, the ECG control was within limits (Fig. 2). The
patient was admitted to an operative unit of medicine where, in the
next day, punctiform rash spread to the face, trunk and thighs and
diagnosing of measles was performed; the body temperature was
37.7 °C. The ECGmonitoring did not show Brugada pattern. In consider-1. Introduction
Brugada syndrome is an autosomal dominant arrhythmogenic
disease with incomplete penetrance due, in 25–30% of cases, to an
alteration sodium channel, secondary to a mutation of SCN5A gene;
from the electrocardiographic point of view is characterized by an
elevation of the ST segment in right precordial leads V1 to V3 with a
QRS morphology similar to a right bundle branch block. The isolated
presence of that electrocardiographic pattern does not constitute a
high risk of sudden cardiac death, but poses several problems in the
order to the quantiﬁcation of the same and for the type of follow-up
to be established for these patients [1].
2. Case report
A healthy 31-year-old male, with no cardiovascular risk factors
and no relevant clinical history, was referred to our department for
symptoms characterized by intermittent fever, cough, and chest
pain for about 5 days and resistant to therapy with paracetamol,
corticosteroids and antibiotics.
The blood sample showed leukopenia and increase the indices of
inﬂammation. The patient was subjected to hematological advice,
abdominal ultrasound, chest radiography and chest computed tomog-
raphy, investigations being all normal.
The ECG performed in emergency room showed a right bundle
branch block with ST-segment elevation in V1–V2 and for the persis-
tence of chest pain a cardiology consult in emergency was requested,
in which blood pressure was found normal (110/70 mm Hg) and039 1 6554304.
dramis).
Ltd. All rights reserved.manifested fever (39.5 °C).The ECG showed sinus tachycardia and
ation of the ECG and the risk proﬁle, accordingwith the current Consen-
sus Report on the Brugada syndrome [3,4], it was decided not to submit
the patient to further investigation, but to a close follow-up. Currently
scientiﬁc evidence indicates in these patients that it is important to
check serum electrolytes and perform periodic ECG, Holter, counteract
effectively fever and avoid certain drugs that are arrhythmogenic or
with negative effect on the electrical fault of the disease.3. Conclusions
Scientiﬁc evidence now indicates that in patients with Brugada
syndrome, and in patients with a spontaneous type 1 ECG with no
history of syncope and without familiarity (Brugada type pattern), it
is important to check serum electrolytes such as magnesium, potassi-
um, calcium, sodium, chlorine, andmake periodic ECG and Holter mon-
itoring. During any ﬂu syndrome, fever is an element to be monitored
immediately at the onset with adequate treatment of pyrexia [2].
On the basis of clinical evidence, in patients suffering from Brugada
syndrome or pattern-like Brugada, should strictly avoid taking certain
medications such as many antiarrhythmics, psychotropics, anesthetics,
analgesics, and alcohol abuse, since they have arrhythmogenic effect
or with negative effect on the electrical fault of the disease [3].
The previous history of syncope is the most important indicator
for a poor prognosis. In the presence of a spontaneous diagnostic
ECG, associated with a history of syncope, the implantation of a deﬁ-
brillator in primary prevention is therefore justiﬁed [5]. The thera-
peutic procedure is complicated in the case in which we are dealing
with a patient with a spontaneous type 1 ECG with no history of syn-
cope and no family history, just as in the case report presented.
In the largest cohort of patients with Brugada syndrome so far
studied (FINGER Brugada Syndrome Registry) [1], the risk of arrhyth-
mic events was low in asymptomatic patients (prevalence 0.5%). The
presence of syncopal events, cardiac arrest and type 1 electrocardio-
graphic pattern was the only independent predictor of arrhythmic
events. However, today, it is not possible to identify with absolute
Fig. 1. ECG at the admission with sinus tachycardia and coved type Brugada pattern in conjunction with temperature increasing (39.5 °C).
Fig. 2. ECG during defervescence.
e42 G. Coppola et al. / International Journal of Cardiology 165 (2013) e41–e42certainty a uniform and shared behavior about the duration and type
of follow-up for all those patients with similar characteristics to those
presented by us.
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